Leveraging GPCR signaling in thermogenic fat to counteract metabolic diseases
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Leveraging GPCR signaling in thermogenic fat to counteract metabolic diseases. / Sveidahl Johansen, Olivia; Ma, Tao; Gerhart-Hines, Zachary.
I: Molecular Metabolism, Bind 60, 101474, 2022.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Leveraging GPCR signaling in thermogenic fat to counteract metabolic diseases
AU - Sveidahl Johansen, Olivia
AU - Ma, Tao
AU - Gerhart-Hines, Zachary
N1 - Publisher Copyright: © 2022 The Author(s)
PY - 2022
Y1 - 2022
N2 - Background: Thermogenic brown and beige adipocytes are recognized for their unique capacity to consume extraordinary levels of metabolites and lipids from the blood to fuel heat-producing catabolic processes [1–7]. In humans, the functions of thermogenic adipocytes are associated with cardiometabolic protection and improved glycemic control [8–13]. Consequently, engaging these macronutrient-consuming and energy-dissipating activities has gained attention as a promising therapeutic strategy for counteracting metabolic diseases, such as obesity and diabetes. Scope of review: In this review, we highlight new advances in our understanding of the physiological role of G protein-coupled receptors (GPCRs) in controlling thermogenic adipocyte biology. We further extend our discussion to the opportunities and challenges posed by pharmacologically targeting different elements of GPCR signaling in these highly specialized fat cells. Major conclusions: GPCRs represent appealing candidates through which to harness adipose thermogenesis. Yet safely and effectively targeting these druggable receptors on brown and beige adipocytes has thus far proven challenging. Therefore, continued interrogation across the GPCR landscape is necessary for future leaps within the field of thermogenic fat biology to unlock the therapeutic potential of adipocyte catabolism.
AB - Background: Thermogenic brown and beige adipocytes are recognized for their unique capacity to consume extraordinary levels of metabolites and lipids from the blood to fuel heat-producing catabolic processes [1–7]. In humans, the functions of thermogenic adipocytes are associated with cardiometabolic protection and improved glycemic control [8–13]. Consequently, engaging these macronutrient-consuming and energy-dissipating activities has gained attention as a promising therapeutic strategy for counteracting metabolic diseases, such as obesity and diabetes. Scope of review: In this review, we highlight new advances in our understanding of the physiological role of G protein-coupled receptors (GPCRs) in controlling thermogenic adipocyte biology. We further extend our discussion to the opportunities and challenges posed by pharmacologically targeting different elements of GPCR signaling in these highly specialized fat cells. Major conclusions: GPCRs represent appealing candidates through which to harness adipose thermogenesis. Yet safely and effectively targeting these druggable receptors on brown and beige adipocytes has thus far proven challenging. Therefore, continued interrogation across the GPCR landscape is necessary for future leaps within the field of thermogenic fat biology to unlock the therapeutic potential of adipocyte catabolism.
KW - Brown adipose tissue
KW - Cell signaling
KW - Diabetes
KW - Energy expenditure
KW - G protein-coupled receptor
KW - Obesity
U2 - 10.1016/j.molmet.2022.101474
DO - 10.1016/j.molmet.2022.101474
M3 - Review
C2 - 35339729
AN - SCOPUS:85128545982
VL - 60
JO - Molecular Metabolism
JF - Molecular Metabolism
SN - 2212-8778
M1 - 101474
ER -
ID: 305686546